Florida Sues Eli Lilly, Novo Nordisk and Pharmacy Benefit Managers Over Insulin Pricing - PYMNTS.com
Why now
Thesis: Insulin pricing faces new legal pressure
Catalyst to watch: Court filings and settlement news
Main risk: Suits may be dismissed or slow-moving
Why it matters
State litigation over insulin pricing adds legal and pricing pressure to diabetes drugmakers and PBMs.
Sources
- googlenews · news.google.com · 2026-09-23 18:40 UTC